vs
Side-by-side financial comparison of Organon & Co. (OGN) and Teradyne (TER). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× Teradyne). Teradyne runs the higher net margin — 23.7% vs -13.6%, a 37.3% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (43.9% vs -5.3%). Teradyne produced more free cash flow last quarter ($218.8M vs $96.0M). Over the past eight quarters, Teradyne's revenue compounded faster (34.4% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.
OGN vs TER — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.1B |
| Net Profit | $-205.0M | $257.2M |
| Gross Margin | 49.2% | 57.2% |
| Operating Margin | -9.8% | 27.1% |
| Net Margin | -13.6% | 23.7% |
| Revenue YoY | -5.3% | 43.9% |
| Net Profit YoY | -288.1% | 75.9% |
| EPS (diluted) | $-0.78 | $1.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.6B | $769.2M | ||
| Q2 25 | $1.6B | $651.8M | ||
| Q1 25 | $1.5B | $685.7M | ||
| Q4 24 | $1.6B | $752.9M | ||
| Q3 24 | $1.6B | $737.3M | ||
| Q2 24 | $1.6B | $729.9M | ||
| Q1 24 | $1.6B | $599.8M |
| Q4 25 | $-205.0M | $257.2M | ||
| Q3 25 | $160.0M | $119.6M | ||
| Q2 25 | $145.0M | $78.4M | ||
| Q1 25 | $87.0M | $98.9M | ||
| Q4 24 | $109.0M | $146.3M | ||
| Q3 24 | $359.0M | $145.6M | ||
| Q2 24 | $195.0M | $186.3M | ||
| Q1 24 | $201.0M | $64.2M |
| Q4 25 | 49.2% | 57.2% | ||
| Q3 25 | 53.5% | 58.4% | ||
| Q2 25 | 54.8% | 57.2% | ||
| Q1 25 | 55.6% | 60.6% | ||
| Q4 24 | 56.3% | 59.4% | ||
| Q3 24 | 58.3% | 59.2% | ||
| Q2 24 | 58.4% | 58.3% | ||
| Q1 24 | 59.0% | 56.6% |
| Q4 25 | -9.8% | 27.1% | ||
| Q3 25 | 15.2% | 18.9% | ||
| Q2 25 | 14.4% | 13.9% | ||
| Q1 25 | 6.7% | 17.6% | ||
| Q4 24 | 8.1% | 20.4% | ||
| Q3 24 | 13.1% | 20.6% | ||
| Q2 24 | 14.6% | 28.8% | ||
| Q1 24 | 14.5% | 13.0% |
| Q4 25 | -13.6% | 23.7% | ||
| Q3 25 | 10.0% | 15.5% | ||
| Q2 25 | 9.1% | 12.0% | ||
| Q1 25 | 5.8% | 14.4% | ||
| Q4 24 | 6.8% | 19.4% | ||
| Q3 24 | 22.7% | 19.8% | ||
| Q2 24 | 12.1% | 25.5% | ||
| Q1 24 | 12.4% | 10.7% |
| Q4 25 | $-0.78 | $1.62 | ||
| Q3 25 | $0.61 | $0.75 | ||
| Q2 25 | $0.56 | $0.49 | ||
| Q1 25 | $0.33 | $0.61 | ||
| Q4 24 | $0.42 | $0.89 | ||
| Q3 24 | $1.38 | $0.89 | ||
| Q2 24 | $0.75 | $1.14 | ||
| Q1 24 | $0.78 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $293.8M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $2.8B |
| Total Assets | $12.9B | $4.2B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $293.8M | ||
| Q3 25 | $672.0M | $272.7M | ||
| Q2 25 | $599.0M | $339.3M | ||
| Q1 25 | $547.0M | $475.6M | ||
| Q4 24 | $675.0M | $553.4M | ||
| Q3 24 | $763.0M | $510.0M | ||
| Q2 24 | $704.0M | $421.9M | ||
| Q1 24 | $575.0M | $707.4M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $2.8B | ||
| Q3 25 | $906.0M | $2.7B | ||
| Q2 25 | $733.0M | $2.8B | ||
| Q1 25 | $542.0M | $2.8B | ||
| Q4 24 | $472.0M | $2.8B | ||
| Q3 24 | $493.0M | $2.9B | ||
| Q2 24 | $144.0M | $2.7B | ||
| Q1 24 | $48.0M | $2.6B |
| Q4 25 | $12.9B | $4.2B | ||
| Q3 25 | $13.6B | $4.0B | ||
| Q2 25 | $13.5B | $3.8B | ||
| Q1 25 | $13.2B | $3.7B | ||
| Q4 24 | $13.1B | $3.7B | ||
| Q3 24 | $12.8B | $3.8B | ||
| Q2 24 | $12.2B | $3.6B | ||
| Q1 24 | $11.9B | $3.4B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $281.6M |
| Free Cash FlowOCF − Capex | $96.0M | $218.8M |
| FCF MarginFCF / Revenue | 6.4% | 20.2% |
| Capex IntensityCapex / Revenue | 3.0% | 5.8% |
| Cash ConversionOCF / Net Profit | — | 1.09× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $450.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $281.6M | ||
| Q3 25 | $264.0M | $49.0M | ||
| Q2 25 | $220.0M | $182.1M | ||
| Q1 25 | $75.0M | $161.6M | ||
| Q4 24 | $390.0M | $282.6M | ||
| Q3 24 | $141.0M | $166.3M | ||
| Q2 24 | $332.0M | $216.1M | ||
| Q1 24 | $76.0M | $7.3M |
| Q4 25 | $96.0M | $218.8M | ||
| Q3 25 | $218.0M | $2.4M | ||
| Q2 25 | $181.0M | $131.7M | ||
| Q1 25 | $43.0M | $97.6M | ||
| Q4 24 | $335.0M | $225.2M | ||
| Q3 24 | $99.0M | $114.4M | ||
| Q2 24 | $300.0M | $171.2M | ||
| Q1 24 | $30.0M | $-36.7M |
| Q4 25 | 6.4% | 20.2% | ||
| Q3 25 | 13.6% | 0.3% | ||
| Q2 25 | 11.4% | 20.2% | ||
| Q1 25 | 2.8% | 14.2% | ||
| Q4 24 | 21.0% | 29.9% | ||
| Q3 24 | 6.3% | 15.5% | ||
| Q2 24 | 18.7% | 23.5% | ||
| Q1 24 | 1.8% | -6.1% |
| Q4 25 | 3.0% | 5.8% | ||
| Q3 25 | 2.9% | 6.1% | ||
| Q2 25 | 2.4% | 7.7% | ||
| Q1 25 | 2.1% | 9.3% | ||
| Q4 24 | 3.5% | 7.6% | ||
| Q3 24 | 2.7% | 7.0% | ||
| Q2 24 | 2.0% | 6.1% | ||
| Q1 24 | 2.8% | 7.3% |
| Q4 25 | — | 1.09× | ||
| Q3 25 | 1.65× | 0.41× | ||
| Q2 25 | 1.52× | 2.32× | ||
| Q1 25 | 0.86× | 1.63× | ||
| Q4 24 | 3.58× | 1.93× | ||
| Q3 24 | 0.39× | 1.14× | ||
| Q2 24 | 1.70× | 1.16× | ||
| Q1 24 | 0.38× | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
